Welcome to our dedicated page for VLNCF news (Ticker: VLNCF), a resource for investors and traders seeking the latest updates and insights on VLNCF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VLNCF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VLNCF's position in the market.
The Valens Company (OTCQX: VLNCF) announced a custom manufacturing agreement with TREC Brands to launch vape cartridges for its WINK brand. The first two products, WINK Onyx and WINK Chalice, leverage a broad-spectrum CO2 extraction process, offering high THC formulations. WINK Chalice, a Sativa-dominant blend, features earthy and floral notes, while WINK Onyx, an Indica-dominant option, has floral and citrus flavors. Currently available in Alberta, these products will expand to Ontario soon. TREC Brands will donate 10% of profits to community initiatives.
The Valens Company (OTCQX: VLNCF) announced the launch of Summit 10, a new cannabis-infused beverage containing 10mg of THC, in partnership with A1 Cannabis Company. This product is the third in their beverage line, enhancing potency and flavor compared to the previous 2.5mg THC offerings. Summit 10 utilizes SōRSE by Valens technology and is designed for quicker effects and controlled consumption. It is set to debut in mid-October in Alberta, followed by launches in British Columbia and Ontario, with a zero-sugar variant also expected shortly.
The Valens Company (TSX: VLNS) (OTCQX: VLNCF) reported a significant increase in its product SKUs, reaching 56 in Q3 2020, marking a 56% rise from Q2 2020's 36 SKUs. This growth is attributed to new partnerships and the fulfillment of existing contracts in response to demand for oil-based products in Canada. The company successfully shipped its first products to Australia in collaboration with Cannvalate Pty Ltd. Financial results for the quarter are forthcoming, with no guidance provided at this time.
The Valens Company, a leader in cannabinoid-based product development, has received a Cannabis Research Licence from Health Canada. This licence allows the company to conduct human trials assessing the sensory evaluation of its cannabis extracts and products. CEO Tyler Robson highlighted that this milestone enhances their innovative capabilities and helps ensure product quality. The research will support the development of a diverse range of cannabis products, including edibles and beverages, further solidifying Valens' position in the market.
